(EMAILWIRE.COM, March 10, 2015 ) Dallas, TX — Global Markets DirectÂ’s, ‘Secondary Hyperparathyroidism Pipeline Review, H1 2015 , provides an overview of the Secondary HyperparathyroidismÂ’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development…
http://www.emailwire.com/release/179561-Secondary-Hyperparathyroidism-Therapeutic-Development-H1-2015.html